Corcept Therapeutics | CORT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Alaunos Therapeutics USD 864K 269K 2026-06
ANI Pharmaceuticals USD 328.72M 45.06M 2026-09
Ardelyx USD 127.8M 4.42M 2026-09
Aurora Cannabis CAD 73.43M 6.5M 2026-06
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Canopy Growth CAD 166.75M 8.31M 2026-06
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Eli Lilly USD 47B 745M 2026-09
J&J USD 55.46B 562M 2026-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Merck USD 28.8B 1.07B 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 32.52B 777M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 126.1M 4.08M 2026-09
Pfizer USD 31.73B 920M 2026-09
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
TG Therapeutics USD 260.53M 7.97M 2026-09